Ireland· IE-PA-PA22720/013/001
Pentamidine Tillomed 300 mg powder for solution for injection/infusion or powder for nebuliser solution
A pentamidine isethionate product containing pentamidine isethionate, registered in Ireland by Tillomed Pharma GmbH. The same ATC class is registered in 10 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Pentamidine isethionate is registered in 10 of 19 countries.
Countries holding a registration under ATC P01CX01 (pentamidine isethionate), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 5 of them publish a price we can compare per daily dose
Pentamidine isethionate · ATC P01CX01
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- United Statesprice
Price per daily dose
What a daily dose of pentamidine isethionate costs, country by country.
Normalised to the WHO defined daily dose (0.28 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pentamidine isethionate · price per daily dose (0.28 g)
USD · FX 28 Sept 2026
- CH Switzerland$36.41
The record
At a glance
HPRA (Ireland)- Active substance
- Pentamidine isethionate
- Manufacturer
- Tillomed Pharma GmbH
- Country
- Ireland (IE)
- ATC code
- P01CX01
- ATC class
- Pentamidine isethionate
- Defined daily dose
- 0.28 g, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA22720/013/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
447 interactions on record for pentamidine isethionate.
Graded by severity as the source publishes them — 103 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pentamidine isethionate · interactions on record
447 records
- 103 severe
- 296 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
45 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pentamidine isethionate in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyPentacarinatThe Simple Pharma Company Limited
- United StatesNebuPentFresenius Kabi USA, LLC
- FinlandPentacarinatsanofi-Aventis Oy
- CanadaPENTAMIDINE ISETIONATE FOR INJECTION BPMARCAN PHARMACEUTICALS INC
- CzechiaPENTACARINAT
- SwedenPentacarinat 300 mg Pulver till injektions-/infusions-/nebulisatorvätska, lösningEbb Medical AB
- FrancePENTAMIDINE TILLOMED 300 mg, poudre pour solution injectable/pour perfusion ou pour inhalation par nébuliseurTILLOMED PHARMA (ALLEMAGNE)
- NorwayPentamidine diisetionate TillomedTillomed Pharma GmbH - Schönefeld
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Belgium · Pentacarinat
- Germany · Pentacarinat, Pentamidindiisetionat Tillomed
- Denmark · Pentamidine Tillomed
- Spain · Pentacarinat
- Finland · Pentamidine Tillomed
- France · Pentacarinat, Pentamidine Tillomed
- United Kingdom (Northern Ireland) · Pentamidine Isetionate Tillomed
- Italy · Pentacarinat
- Luxembourg · Pentacarinat
- Netherlands · Pentacarinat, Pentamidinediisetionaat Tillomed
- Norway · Pentamidine Diisetionate Tillomed
- Sweden · Pentamidine Tillomed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/71ffa06d-e47d-4235-b4fd-4b4db228fef4 GET /v1/drugs/71ffa06d-e47d-4235-b4fd-4b4db228fef4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for solution for injection/infusion",
"routes": [
"Inhalation use",
"Intramuscular use",
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"P01CX01"
],
"strength": null,
"pa_number": "PA22720/013/001",
"substances": [
"Pentamidine isethionate"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "21/02/2025",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about pentamidine isethionate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.